Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy
NCT01207908
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Duchenne Muscular Dystrophy
Interventions
DRUG:
IGF-1
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
[object Object]
[object Object]